Shantanu Kumar Singh Taj Pharma: Latest News, Videos and Photos of Shantanu Kumar Singh Taj Pharma | Times of India Shantanu Kumar Singh Taj Pharma News: Latest and Breaking News on Shantanu Kumar Singh Taj Pharma. Explore Shantanu Kumar Singh Taj Pharma profile at Times of India for photos, videos and latest news of Shantanu Kumar Singh Taj Pharma. Also find news, photos and videos on Shantanu Kumar Singh Taj Pharma Shantanu Kumar Singh Taj Pharma, Shantanu Kumar Singh Taj Pharma news, Shantanu Kumar Singh Taj Pharma latest news, Shantanu Kumar Singh Taj Pharma biography, Shantanu Kumar Singh Taj Pharma photos

1. Thismeansitislessbeholdentolocal
authorityfunding,whichhasplummeted
inrecentyears,pilingpressureonthe
widersector.
TajPharmaceuticalschemotherapy
divisionpaidoffa£0.9milliondebtfive
yearsagothroughthesaleandleaseback
of2OncologycarehospitalsinSaint
Petersburgtoapropertyinvestment
business,CrosswellInternational,which
wasbackedbyprivateinvestorsat
Moscow.
Labels:tajoncology,tajpharmaceutical
chemotherapydivision,tajoncology
chemotherapycompanies,
Chemotherapydrugs—Taj
Pharmaceuticals,tajchemotherapy
manufacturer,tajpharmaceutical
Chemotherapy,tajpharmaceutical
Chemotherapy,manufacturersoftaj
pharmaceuticalsoncology,Taj
pharmaceuticalschemicalsApiAgro
Products,tajpharmaceuticaloncology
india
 Indian pharmaceuticals businessmen Abhishek Singh, Taj Pharmaceuticals Limited and Priyanka Singh could be in for a major
windfall as one of Indian’s leading oncology care division manufacturing groups old unit is to be put up for sale in a deal that could
net its owners north of £2.5 million.
 This same in will lead to a further expansion of newly built Taj Oncology (chemotherapy drugs) Unit based in the Indian Territory;
Sources have not confirmed exact details of such new venture; However, the move could be looked at venturing in the regulated
markets of oncology products via an EMA, EU GMP regulated infrastructure with Oncology Section— Tablets, Capsules, Liquid and
Lyophilized Injectables all under single unit.
 Sources confirmed a Press Association report yesterday that the owners of Taj Pharmaceuticals— including Dr.Ranveer Kumar Singh
(Chairman), Mr Abhishek Singh (Director), Priyanks Singh and Shantanu Singh (Executive Director)— have mandated investment
banks and private equity holders to assess their options, the most likely of which is a sale.
 The businessmen own Taj Pharmaceuticals Oncology Unit through their private investment vehicle Singh Investments SPA, and a
formal sale process could be kicked off within weeks.
 It is thought that several buyers have already expressed an interest, but only offers higher than £2.5 million are being taken seriously.
 Dr.Ranvir Kumar Singh and Abhishek Singh (Director) and Priyanks Singh are close associates and have been involved in a number of
ventures together, including ownership of a stake in several pharmaceuticals manufacturing units which they sold in 2014.
 Trio sibling directors are best known here for their involvement in Russia and CIS markets, mainly, Armenia, Azerbaijan, Belarus,
Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Uzbekistan. Ms Priyanka Singh is one
of the partners behind Russia and CIS front, with more than 500 registered pharmaceutical products in state owned approx 1300–
1800 state owned pharmacies in CIS nations; which gives vast reach to the anti-cancer products and Mr Shantanu Singh for his
ownership of national distribution channel cooperation’s “stazs” such based at Saint Petersburg.
 Chemotherapy drug patients
 Taj Pharmaceuticals Oncology division currently boasts over 20 anti-cancer drug hospitals in Russia and CIS nations that house
11,000 chemotherapy patients people and employ 17,000 staff; who could be in severe drug shortage and budgetary constrains; if
such chemotherapy drugs has to be purchased from the open market at retain prices; making such chemotherapy centers to be non-
viable for poor and needy patients in India.
 Latest accounts filed with Ministry for Economic Developmentof the Russian Federation show that Taj Pharma Russia’s turnover
increased 5.3 per cent to £1.9 million in 2016, with operating profit coming in 5.6 per cent higher at £1.3 million.
 The Indian pharmaceuticals trio Mr.Abhishek Singh, Mr.Shantanu Singh and Priyanka Singh first invested in Taj Pharmaceuticals
Oncology Division in 2004, a year after the company was set up by father Dr Ranvir Singh, and are in line for a bumper payday if a
deal goes ahead and a further expansion into bigger and better infrastructure with regulatory approvals.
 Its attraction to a potential buyer for old oncology division, likely to be a private equity firm, is the fact that Taj Pharma’s primary
focus is on privately-paying residents.
Tags: chemotherapydrugs | Indian pharmaceuticalsmillionaires |
oncology generics | taj pharma | Taj Pharmaceuticals Limited | Trio of
Indian pharmaceuticals